Global Antimicrobial Susceptibility Testing Market
Healthcare Services

Global Antimicrobial Susceptibility Testing Market Opportunities And Strategies 2023

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s antimicrobial susceptibility testing market report forecasts the antimicrobial susceptibility testing market size to grow to $4.94 Billion by 2027, with a CAGR (compound annual growth rate) of 6%.

Learn More On The Antimicrobial Susceptibility Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/antimicrobial-susceptibility-testing-global-market-report

Antimicrobial Susceptibility Testing Market Size Forecast
The global antimicrobial susceptibility testing market is expected to grow from $3.67 billion in 2022 to $3.91 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The antimicrobial susceptibility testing market size is expected to grow to $4.94 billion in 2027 at a CAGR of 6.0%.

North America held the largest antimicrobial susceptibility testing market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Antimicrobial Susceptibility Testing Market Driver ­– Rise In The Incidence Of Infectious Diseases Globally
According to World Health Organization (WHO), in 2021,, an estimated 10.6 million people are infected with tuberculosis globally, 1.6 million died, and 1.5 million people acquired HIV in 2021 while 650,000 people lost lives due to it. This increase in the incidence of infected people boosted the use of susceptibility testing of the organisms to develop the most effective drugs and this, in turn, drove the market for antimicrobial susceptibility testing.

Request for A Sample Of The Global Antimicrobial Susceptibility Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4026&type=smp

Key Antimicrobial Susceptibility Testing Market Trend – Adopting Rapid Antimicrobial Susceptibility Testing
Rapid antimicrobial susceptibility testing is increasingly being used to avoid misuse of antibiotics and to provide effective treatment and this is emerging as a key trend in the antimicrobial susceptibility testing market. There are many ways to perform antimicrobial susceptibility testing in minutes or a few hours. FISH (Fluorescence in situ hybridization) is mostly used in rapid antimicrobial susceptibility testing. The PNA-FISH applies peptide nucleic acid probes that allow rapid and specific binding, this process is applied in QuickFish technology (OpGen) which performs identification of microbial by targeting 16s RNA. For instance, the antimicrobial susceptibility testing system by Genefluidics Inc measures bacterial growth by quantifying 16s rRNA molecules using an electrochemical biosensor.

Antimicrobial Susceptibility Testing Market Segment
1) By Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Types
2) By Products: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications
4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)

Antimicrobial Susceptibility Testing Market Major Players and Strategies
Major players in the antimicrobial susceptibility testing market are BioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Accelerate Diagnostics, Hi-Media Laboratories, Creative Diagnostics, Merck KGaA, Roche Diagnostics Limited, BD, Alifax Holding S.p.A., Synbiosis, Zhuhai DL Biotech Co, Mast Group, ELITechGroup, Genefluidics, Mast Group, CONDALAB, and QuantaMatrix.

The Antimicrobial Susceptibility Testing Global Market Report 2023 covers regional data on antimicrobial susceptibility testing market size, antimicrobial susceptibility testing market trends and drivers, opportunities, strategies, and antimicrobial susceptibility testing market competitor analysis. The countries covered in the antimicrobial susceptibility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Antimicrobial susceptibility testing (AST) is a laboratory procedure done by clinical laboratory professionals to identify which antimicrobial specimen is specifically effective for individual patients. The antimicrobial susceptibility testing market consists of sales of antimicrobial susceptibility testing by entities (organizations, sole traders and partnerships) that are engaged in laboratory services that provide antimicrobial susceptibility testing.

View More Reports Related To The Antimicrobial Susceptibility Testing Market –
Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023
Antimicrobial Medical Device Coatings Global Market Report 2023
Antimicrobial Textile Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas
+1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn:
https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: